Breast Cancer News

CancerConnect breast cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of breast cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of breast cancer treatment and survivorship.

Share


Recent Breast Cancer News


The Novel Small Molecule Pictilisib May Benefit Women with Advanced Breast Cancer (March 5, 2015)

CancerConnect News:  The addition of the investigational drug pictilisib to Faslodex® (fulvestrant) has been demonstrated to delay the time of cancer in women with advanced or metastatic breast cancer... Continue Reading

Palbociclib/Letrozole Improves Outcomes of Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer (February 27, 2015)

The results of the phase II PALOMA-1/TRIO-18 trial were recently reported in The Lancet Oncology and suggest that the addition of Ibrance® (palbociclib) to Femara® (letrozole) delayed the time to cancer... Continue Reading

Afinitor® plus Herceptin® and Paclitaxel Effective in Advanced Hormone Receptor-Negative HER2-Positive Breast Cancer (February 5, 2015)

The combination of Afinitor® (everolimus) plus Herceptin® (trastuzumab) paclitaxel appears effective for patients with advanced HER2-positive breast cancer that is hormone receptor (HR)-negative. These... Continue Reading

Low-Fat Diet May Help Prevent Certain Breast Cancers (February 4, 2015)

Women who lower their fat intake may have a reduced risk of estrogen receptor (ER)-positive/progesterone receptor (PR)-negative breast cancer. These findings were published in Cancer Epidemiology, Biomarkers... Continue Reading

Breast Cancer Research: Have We Made Progress? (January 27, 2015)

Published results from research studies in breast cancer in the last year represent several practice changing milestones. CancerConnect News coverage of advances in the management of breast cancer included... Continue Reading

Breakthrough Mayo Clinic Study Confirms Molecular Breast Imaging (MBI) High Absolute Sensitivity for Supplemental, Low-Dose Screening Studies in Women with Dense Breast Tissue (January 26, 2015)

A breakthrough study conducted by Mayo Clinic and published in the AJR has clinically confirmed that Molecular Breast Imaging (MBI) yields superior imaging and low radiation exposure for women with dense... Continue Reading

Study Confirms Role of Ovarian Suppression and Aromasin for Younger Women With Hormone-sensitive Breast Cancer (December 19, 2014)

CancerConnect News: Ovarian suppression combined with the anti-estrogen drug Aromasin® (exemestane) appears to greatly reduce the risk of breast cancer recurrence in younger women according to the results... Continue Reading

Breast Cancer Patients Are Now Living Longer without Relapse (December 18, 2014)

CancerConnect News: Survival without relapse for patients with early-stage breast cancer has improved significantly over the past 30 years, particularly among women with HER2-positive disease. These findings... Continue Reading

Some Older Women with Early-Stage Breast Cancer May Be Receiving Radiation That Is Unlikely to Add Benefit (December 17, 2014)

CancerConnect News Up to two-thirds of older women with early-stage breast cancer may be receiving radiation therapy that may not provide additional benefit. These findings were recently released online... Continue Reading

IBIS-I Trial Confirms Greater Than Fifteen Year Benefit of Tamoxifen to Reduce Risk of Breast Cancer in High-Risk Women (December 16, 2014)

CancerConnect News: Long term results of the International Breast Cancer Intervention Study-I (IBIS-I) were presented at the 2014 San Antonio Breast Cancer Symposium, confirming that tamoxifen significantly... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS